SATI.AQSE

Sativa Investments plc
Sativa Group PLC - Conditional CSE Approval of Sativa Wellness Group
10th September 2020, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5445Y
Sativa Group PLC
10 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Sativa Group Plc
("Sativa" or the "Company" or the "Group")

Conditional CSE Approval of Sativa Wellness Group Inc

10 September 2020

 

The Company is pleased to announce that the Canadian Securities Exchange ("CSE") conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa shareholders voted 99% in favour of the merger, with Stillcanna shareholders voting 99.9% in favour, and the Court sanctioned the Scheme of Arrangement, subject to unconditional CSE approval. Unconditional approval and the resumption of trading on the CSE of Sativa Wellness Group Inc. is expected within the next 12 days, with a quotation on the AQSE Growth Market expected around the same time.    

 

The new Sativa Wellness officers are Henry Lees-Buckley as Chief Executive Officer, Joseph Colliver as Chief Financial Officer, both Board Directors, and Anne Tew as Corporate Secretary. The Board of Directors will also include Jonathan Wearing as Chairman, and Angus Kerr, Mark Blower and Jason Dussault as Directors. Jason will additionally be leading our Investor Relations efforts.    

 

A new corporate website that will be AQSE Growth Market Rule 71 compliant on admission, has been launched for shareholders and investors to gain further information. Please go online to www.sativawellnessgroup.com. The new trading symbol, (ticker), will be "SWEL" for the Sativa Wellness trading on the CSE and AQSE.

 

The newly released corporate video, housed on our new Sativa Wellness Group YouTube channel, explains how we have created a fully integrated European seed to consumer offering. By having the stewardship of the product through the entire supply chain it will allow us to not only deliver consistent quality to our consumers, but also CBD you can trust from the ability to be fully compliant with all UK industry regulations such as the FSA Novel Foods Accreditation.

The directors of the Company accept responsibility for the contents of this announcement.

Enquiries:

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc

+44 (0) 20 7971 1255

enquiries@sativagroup.co.uk

www.sativagroup.co.uk

 

Joseph Colliver

Chief Financial Officer

Sativa Group Plc

+44 (0) 20 7971 1255

enquiries@sativagroup.co.uk

www.sativagroup.co.uk

 

AQSE Growth Market Corporate Adviser

Corporate Finance 

Guy Miller/Allie Feuerlein

Peterhouse Capital Limited

+44 (0) 20 7220 9795


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXKKLFBBKLEBBZ ]]>
TwitterFacebookLinkedIn